Faculty

• 

• Javier Cortés, MD

  Head
  International Breast Cancer Centre
  Founding Partner
  Medica Scientia Innovation Research
  Barcelona, Spain

  Disclosures

  Consultant or advisor for: Athenex; AstraZeneca; Boehringer Ingelheim; BiOasis; BioInvent; Celgene; Cellestia; Clovis Oncology; Daiichi Sankyo; Ellipses; Erytech; GEMoaB; Gilead; GlaxoSmithKline; HiberCell; Leuko; Lilly; Menarini; Merck Sharp & Dohme; Polyphor; Roche; Seagen Inc., formerly Seattle Genetics, Inc.; Zymeworks
  Speaker or member of speakers bureau for: Celgene; Daiichi Sankyo; Eisai; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Samsung Bioepis
  Research funding from: Ariad Pharmaceuticals; AstraZeneca; Baxalta GMBH; Bayer Healthcare; Eisai; F. Hoffman-La Roche; Guardant Health; Merck Sharp & Dohme; Pfizer; PIQUR Therapeutics; Puma; Roche; Servier Affaires Medicales
  Stock options from: MedSIR; Nektar Therapeutics

• 

• Hope S. Rugo, MD

  Professor of Medicine
  University of California San Francisco
  Helen Diller Family Comprehensive Cancer Center
  Director
  Breast Oncology and Clinical Trials Education
  San Francisco, California, United States

  Disclosures

  Speaker or member of speakers bureau for: Honoraria from: Mylan; NAPO; Puma; Samsung
  Research funding from: AstraZeneca; Ayala; Boehringer Ingelheim; Daiichi Sankyo; Gilead; Lilly; Macrogenics; Merck; Novartis; Pfizer; Polyphor; Roche; Seagen Inc., formerly Seattle Genetics, Inc.; Sermonix

Editor

• Walid Amara, MD

  Medical Education Director, WebMD Global, LLC

  Disclosures

  Disclosure: Walid Amara, MD, has no relevant financial relationships.

Compliance Reviewer

• Amanda Jett, PharmD, BCACP

  Associate Director, Accreditation and Compliance

  Disclosures

  Disclosure: Amanda Jett, PharmD, BCACP, has no relevant financial relationships.